General
Preferred name
S-55746
Synonyms
BLC201 (hydrochloride) ()
BLC201 ()
N-(4-hydroxyphenyl)-3-{6-[(3S)-3-[(morpholin-4-yl)methyl]-1,2,3,4-tetrahydroisoquinoline-2-carbonyl]-2H-1,3-benzodioxol-5-yl}-N-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide ()
S55746 ()
S55746 (hydrochloride) ()
BCL201 ()
BCL201 (hydrochloride) ()
S 055746,BCL201 ()
P&D ID
PD098283
CAS
1448584-12-0
1448525-91-4
Tags
available
drug candidate
Drug Status
investigational
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION S55746 (BCL201) is a potent, orally active and selective BCL-2 inhibitor, with a Ki of 1.3 nM and a Kd of 3.9 nM. S55746 (BCL201) has antitumor activity with low toxicity[1].
PRICE 245
DESCRIPTION S55746 hydrochloride (BCL201 hydrochloride) is a potent, orally active and selective BCL-2 inhibitor, with a Ki of 1.3 nM and a Kd of 3.9 nM. S55746 hydrochloride (BCL201 hydrochloride) has antitumor activity with low toxicity[1].
DESCRIPTION S55746 is an orally available BCL-2 specific inhibitor (Ki = 1.3 nM), displaying 70 to 400-fold selectivity for BCL-2 over BCL-XL. (BOC Sciences Bioactive Compounds)
DESCRIPTION S55746 (BLC201) is an effective and selective BCL-2 inhibitor (Ki: 1.3 nM and a Kd of 3.9 nM). (TargetMol Bioactive Compound Library)
Compound Sets
6
BOC Sciences Bioactive Compounds
DrugBank
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
18
Properties
(calculated by RDKit )
Molecular Weight
710.31
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
1
Rotatable Bonds
7
Ring Count
9
Aromatic Ring Count
5
cLogP
6.8
TPSA
96.71
Fraction CSP3
0.3
Chiral centers
1.0
Largest ring
6.0
QED
0.2
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Bcl-2 Family
Bcl-2
Pathway
Apoptosis
Source data